Positron Emission Tomography (PET) Scanners Market Scope, Size, Implementation, Analytical Overview, Forecast 2030

Positron Emission Tomography (PET) Scanners Marke
Positron Emission Tomography (PET) Scanners Market

A clinical imaging technique called positron emission tomography (PET) is used to diagnose a number of illnesses, including cancer and Alzheimer's disease. The fundamental idea behind PET imaging is the detection of two gamma rays that are indirectly released by a radiotracer. Malignant and non-malignant tumours can be distinguished using PET. The Positron Emission Tomography (PET) Scanners Market is predicted to be worth US$ 1,107.6 million in 2019 and US$ 1,549.7 million by the end of 2027.

New nuclear imaging techniques, including positron emission tomography, which makes use of positron emission tomography (PET) scanners, have been made possible in large part due to advancements in nuclear medicine imaging. PET Scanners Market is becoming more and more popular around the world, and as a result, there is an increase in demand for PET scanners. A significant factor that has influenced the growth of the global Positron Emission Tomography (PET) Scanners Market over the past few years is the rising use of nuclear medicine imaging to assess, diagnose, and treat a variety of diseases, including cardiovascular diseases, cancer, gastrointestinal, and neurological diseases. This trend is expected to continue throughout the forecast period.

Increasing prevalence of cancer is expected to propel growth of the Positron Emission Tomography (PET) Scanners Market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S. Moreover, availability of Medicare coverage for PET scanning is also expected to aid in growth of the market. PET/computed tomography (PET-CT) scanners using the radioisotope 18F-fluorodeoxyglucose (FDG) offer high success rate in cancer diagnosis. The use of these scanners is also supported by expanded coverage for PET imaging in cancers that include, lung cancer, breast cancer, melanoma, lymphoma, head and neck cancer, esophageal cancer, colorectal cancer, cervical cancer, myeloma, thyroid cancer and ovarian cancer.

Comments

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Security Robot Market to Reach US$ 11.8 Billion by 2022

Smart Light or Lightning Control Market Estimated to Reach US$ 21.03 Billion by 2023